1 FY08 Restriction Petition Update and Burden Julie Burke Quality Assurance Specialist Technology Center 1600.

Slides:



Advertisements
Similar presentations
Technology Center 1600 Training on Writing Rejections Under 35 U.S.C. § 103.
Advertisements

UNITED STATES PATENT AND TRADEMARK OFFICE A full transcript of this presentation can be found under the Notes Tab. 35 USC 112 (f)*: Identifying Limitations.
RESTRICTION PRACTICE POLYNUCLEOTIDES POLYPEPTIDES AND FRAGMENTS Christopher Low / James Housel TC1600 /AU 1653 (703)
USPTO Restriction Training Materials and Chapter 800 Revisions
Accelerating Patent Prosecution Thursday, October 18, 2012.
G & B Seminar 2006 Claim Drafting Ken Moore.
Filing for a United States Patent “Helpful Hints” U.S. Patent and Trademark Office.
More on Restriction Practice Jim Housel SPE, Art Unit 1648 (703)
1 1 1 AIPLA American Intellectual Property Law Association USPTO Updates Including Glossary Pilot Program Chris Fildes Fildes & Outland, P.C. IP Practice.
Julie Burke TC1600 QAS REJOINDER PRACTICE Julie Burke TC1600 QAS
1 35 USC 112, 1 st paragraph enablement Enablement Practice in TC 1600 Deborah Reynolds, SPE
September 14, U.S.C. 103(c) as Amended by the Cooperative Research and Technology Enhancement (CREATE) Act (Public Law ) Enacted December.
35 U.S.C. 112, Sixth Paragraph MPEP 2181 – 2186 Jean Witz Quality Assurance Specialist Technology Center 1600.
Filing Compliant Reexam Requests Andy Kashnikow SPE, Central Reexamination Unit Andy Kashnikow SPE, Central Reexamination Unit June, 2010.
1 Principles in Restriction Practice TC 1600 Anthony Caputa TC Practice Specialist (571)
Enhanced First Action Interview (EFAI) Pilot Program Wendy Garber Tech Center Director, 2100 United States Patent & Trademark Office.
TC1600 Appeals Practice Jean Witz, Appeals Specialist.
Accelerated Examination Bennett Celsa (TC 1600: QAS)
“REACH-THROUGH CLAIMS”
Determination of Obviousness Practice Under the Genus-Species Guidelines and In re Ochiai; In re Brouwer Sreeni Padmanabhan & James Wilson Supervisory.
Restriction Practice for Nucleic Acid Molecules Julie Burke QAS/PM
Restriction Practice for Genus Claims Species Claims Linking Claims and Markush Claims Julie Burke QAS/PM TC1600.
Determining Obviousness under 35 USC 103 in view of KSR International Co. v. Teleflex TC3600 Business Methods January 2008.
Greg H. Gardella Ex Parte and Inter Partes Reexamination Tactics AIPLA 2010 Winter Institute.
Green Technology Petition Pilot Robert W. Bahr. 2 Green Tech: Discussion Points 1. Authority and Overview: resources / overview 2.Petition Requirement:
Patent Applications Overlapping the Biotechnology and Mechanical Arts THOMAS BARRETT
1 Unity of Invention: Biotech Examples TC1600 Special Program Examiner Julie Burke (571)
RESTRICTING BETWEEN PRODUCT and PROCESS INVENTIONS Bruce Campell Supervisory Patent Examiner Art Unit
Current and Future USPTO Practice RESTRICTION PRACTICES AT THE USPTO 1 © AIPLA 2015.
1 35 U.S.C. § 102(e): The Legislative Fix (S.320) and Serial Abandonment of Provisional Applications Stephen G. Kunin Deputy Commissioner for Patent Examination.
Full First Action Interview (FFAI) Pilot Program Wendy Garber Tech Center Director, 2100 United States Patent & Trademark Office.
Information Disclosure Statements
December 8, Changes to Patent Fees Under the Consolidated Appropriations Act, 2005 (H.R. 4818)(upon enactment) and 35 U.S.C. 103(c) as Amended by.
Utility Requirement in Japan Makoto Ono, Ph.D. Anderson, Mori & Tomotsune Website:
1 ANTICIPATION BY INHERENCY IN PRIOR ART James O. Wilson Supervisory Patent Examiner Technology Center 1600 USPTO (571)
Notice of Proposed Rule Making Affecting Claims That Recite Alternatives 1 Robert Clarke, Director Office of Patent Legal Administration (571)
1 AIPLA Biotech Committee Meeting Washington D.C., October 14, 2004 Jasemine C. Chambers, Ph.D., J.D. Director Technology Center 1600 USPTO (571)
Restriction & Double Patenting Mojdeh Bahar, J.D., M.A., CLP Chief, Cancer Branch Office of Technology Transfer National Institutes of Health U.S. Department.
1 Patent Law in the Age of IoT The Landscape Has Shifted. Are You Prepared? 1 Jeffrey A. Miller, Esq.
U.S. Patent and Trademark Office Technology Center 1600 Michael P. Woodward Unity of Invention: Biotech Examples.
Harnisch, Unity of Invention, and 76 Fed. Reg AIPLA Biotechnology Committee Presentation March 17, 2011 Brian Lathrop, Ph.D., Esq.
To Restrict or Not To Restrict That Is The Question? Divided We Stand! Or Undivided We Stand!! By Joseph K. McKane SPE, Art Unit 1626.
1 Restriction Practice Updates Julie Burke TC1600 Quality Assurance Specialist
3/2/091 PCT Unity of Invention with Pharmaceutical and Chemical Examples Julie Burke TC1600 Quality Assurance Specialist
July 18, U.S.C. 103(c) as Amended by the Cooperative Research and Technology Enhancement (CREATE) Act (Public Law ) Enacted December 10,
Election of Species Joseph K. McKane SPE, Art Unit 1626 April 27, 2004.
1 Rules of Practice Before the BPAI in Ex Parte Appeals 73 Fed. Reg (June 10, 2008) Effective December 10, Fed. Reg (June 10, 2008)
Doc.: IEEE /1129r1 Submission July 2006 Harry Worstell, AT&TSlide 1 Appeal Tutorial Notice: This document has been prepared to assist IEEE
1 Written Description Analysis and Capon v. Eshhar Jeffrey Siew Supervisory Patent Examiner AU 1645 USPTO (571)
Biotech Customer Partnership August 3, 2004 Jasemine C. Chambers, Ph.D., J.D. Director Technology Center 1600 USPTO (571)
Securing Innovation Michael D. Stein Stein, McEwen & Bui LLP 1400 Eye Street, NW Suite 300 Washington, DC (202)
1 When is it NOT Appropriate to Restrict? Julie Burke TC1600 QAS
New Ex Parte Appeal Rules Patent and Trademark Practice Group Meeting January 26, 2012.
Examining Claims for Compliance with 35 U.S.C. 112(a): Part II – Enablement Focus on Electrical/Mechanical and Computer/Software-related Claims August.
Claims and Continuations Final Rule 1 Joni Y. Chang Senior Legal Advisor Office of Patent Legal Administration (571) ,
FY09 Restriction Petition Update; Comparison of US and National Stage Restriction Practice Julie Burke TC1600 Quality Assurance Specialist
UNITED STATES PATENT AND TRADEMARK OFFICE
Restriction Practice for Combinations and Subcombinations
1 Restriction Petition Survey; A Few Helpful Hints Julie Burke TC1600 Special Program Examiner
Chris Fildes FILDES & OUTLAND, P.C. IP Practice in Japan Committee Pre-Meeting AIPLA Annual Meeting, October 20, 2015 USPTO PILOT PROGRAMS 1 © AIPLA 2015.
James Toupin – General Counsel February 1, Summary of Proposed Rule Changes to Continuations, Double Patenting, and Claims.
Claims Proposed Rulemaking Main Purposes É Applicant Assistance to Improve Focus of Examination n Narrow scope of initial examination so the examiner is.
Examination Practice in Applications Presenting “Reach-Through Claims” George Elliott Practice Specialist Technology Center 1600
Double Patenting Deborah Reynolds SPE Art Unit 1632 Detailee, TC1600 Practice Specialist
Bruce Kisliuk Group Director, Technology Center 1600.
Tim Saulsbury -- Continuations in Part
Processes Which Employ Non-Obvious Products
Claims and Continuations Final Rule
Global Innovation Management Workout on Writing a Patent
Claim drafting strategies when filing a European patent application or entering the European phase of a PCT-application Christof Keussen
Presentation transcript:

1 FY08 Restriction Petition Update and Burden Julie Burke Quality Assurance Specialist Technology Center 1600

2 TC 1600 Filings and Restrictions In FY08, TC1600 mailed 42,018 first actions on the merits mailed 21,911 restriction requirements received about 75 restriction petitions  National stage filings of a PCT application under 371  account for 15% of TC1600 applications  yet result in 28% of the petitions  Average restriction petition turnaround time  91 days in FY04-FY07  103 days in FY08  66% of Restriction Petitions were granted in full or in part in FY08

3 Contents FY08 Restriction Petition Update Overview of Burden

4 Restriction and Lack of Unity Petitions Filed in FY04 – FY08

5 Restriction in 111 (a) and Lack of Unity in 371 For FY04 - FY08

6 Restriction Petitions by Workgroup Filed in FY04 to FY08

7 Petition Outcome by Fiscal Year

8 Petition Outcome by Workgroup For FY05

9 Petition Outcome by Workgroup For FY06

10 Petition Outcome By Workgroup FY07

11 Petition Outcome By Workgroup For FY08

12 TYPES OF CONCERNS FY04

13 TYPES OF CONCERNS FY05

14 TYPES OF CONCERNS FY06

15 TYPES OF CONCERNS FY07

16 TYPES OF CONCERNS FY08

17 Contents FY08 Restriction Petition Update Overview of Burden

18 Burden There are two criteria for a proper requirement for restriction between patentably distinct inventions: (A) The inventions must be independent (see MPEP § , § , § ) or distinct as claimed (see MPEP § §806.05(j)); and (B) There would be a serious burden on the examiner if restriction is not required (see MPEP § , § 808, and § ). MPEP 803

19 Prima Facie Showing of Burden For purposes of the initial requirement, a serious burden on the examiner may be prima facie shown by appropriate explanation of separate classification, or separate status in the art, or a different field of search as defined in MPEP § That prima facie showing may be rebutted by appropriate showings or evidence by the applicant. MPEP 803

20 Establishing Burden Where the inventions as claimed are shown to be independent or distinct under the criteria of MPEP § (c) - § , the examiner, in order to establish reasons for insisting upon restriction, must explain why there would be a serious burden on the examiner if restriction is not required. MPEP

21 Establishing Search Burden Thus the examiner must show by appropriate explanation one of the following: (A) Separate classification thereof (B) A separate status in the art when they are classifiable together or (C) A different field of search MPEP

22 Separate classification thereof This shows that each invention has attained recognition in the art as a separate subject for inventive effort, and also a separate field of search. Patents need not be cited to show separate classification. MPEP

23 A separate status in the art when they are classifiable together Even though they are classified together, each invention can be shown to have formed a separate subject for inventive effort when the examiner can show a recognition of separate inventive effort by inventors. Separate status in the art may be shown by citing patents which are evidence of such separate status, and also of a separate field of search. MPEP

24 A different field of search Where it is necessary to search for one of the inventions in a manner that is not likely to result in finding art pertinent to the other invention(s) (e.g., searching different classes /subclasses or electronic resources, or employing different search queries, a different field of search is shown, even though the two are classified together. The indicated different field of search must in fact be pertinent to the type of subject matter covered by the claims. Patents need not be cited to show different fields of search. MPEP

25 Examination Burden (d) the prior art applicable to one invention would not likely be applicable to another invention (e) the inventions are likely to raise different non-prior art issues under 35 U.S.C. 101 and/or 35 U.S.C. 112, first paragraph

26 When Burden Cannot be Shown Where, however, the classification is the same and the field of search is the same and there is no clear indication of separate future classification and field of search, no reasons exist for dividing among independent or related inventions. MPEP

27 Markush Claims A Markush-type claim recites alternatives in a format such as “selected from the group consisting of A, B and C.” See Ex parte Markush, 1925 C.D. 126 (Comm’r Pat. 1925). The members of the Markush group (A, B, and C in the example above) ordinarily must belong to a recognized physical or chemical class or to an art- recognized class. MPEP

28 Burden Analysis for Markush Claims If the members of the Markush group are sufficiently few in number or so closely related that a search and examination of the entire claim can be made without serious burden, the examiner must examine all the members of the Markush group in the claim on the merits, even though they may be directed to independent and distinct inventions. In such a case, the examiner will not follow the procedure described below and will not require provisional election of a single species. See MPEP § MPEP

29 37 CFR Election of Species In the first action on an application containing a generic claim to a generic invention (genus) and claims to more than one patentably distinct species embraced thereby, the examiner may require the applicant in the reply to that action to elect a species of his or her invention to which his or her claim will be restricted if no claim to the genus is found to be allowable.

30 37 CFR Election of Species However, if such application contains claims directed to more than a reasonable number of species, the examiner may require restriction of the claims to not more than a reasonable number of species before taking further action in the application.

31 When Generic Claims are Present In applications where only generic claims are presented, restriction cannot be required unless the generic claims recite or encompass such a multiplicity of species that an unduly extensive and burdensome search would be necessary to search the entire scope of the claim. See MPEP § and § (a). MPEP and (b)

32 When Species Claims are Later Added If applicant presents species claims to more than one patentably distinct species of the invention after an Office action on only generic claims, with no restriction requirement, the Office may require the applicant to elect a single species for examination. MPEP and (b)

33 An Instance of Rejoinder Predicated on Lack of Burden Where the combination is allowable in view of the patentability of at least one of the subcombinations, the restriction requirement between the elected combination and patentable subcombination(s) will be withdrawn; furthermore, any subcombinations that were searched and determined to be allowable must also be rejoined. MPEP (d)

34 Contents FY08 Restriction Petition Update Overview of Burden

35 Questions? Julie Burke Quality Assurance Specialist, TC